Business Description
Minimed Group Inc
NAICS : 339112
SIC : 3841
ISIN : US60365F1093
Total Employee Number:
2,800Description
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.06 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -1.42 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.8 | |||||
3-Year EPS without NRI Growth Rate | -53.1 | |||||
3-Year FCF Growth Rate | -38.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.44 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.38 | |||||
9-Day RSI | 48.79 | |||||
14-Day RSI | 52.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.43 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 165.06 | |||||
Days Sales Outstanding | 89.12 | |||||
Days Payable | 92.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -1.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.75 | |||||
Operating Margin % | -11.06 | |||||
Net Margin % | -18.69 | |||||
EBITDA Margin % | -6.27 | |||||
FCF Margin % | -13.13 | |||||
OCF Margin % | -6.43 | |||||
ROE % | -8.59 | |||||
ROA % | -6.98 | |||||
ROIC % | -4.76 | |||||
ROC (Joel Greenblatt) % | -19.23 | |||||
ROCE % | -4.82 | |||||
Moat Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 35.17 | |||||
PS Ratio | 3.37 | |||||
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 4.38 | |||||
EV-to-EBIT | -29.64 | |||||
EV-to-Forward-EBIT | -41.68 | |||||
EV-to-EBITDA | -52.3 | |||||
EV-to-Forward-EBITDA | 159.63 | |||||
EV-to-Revenue | 3.28 | |||||
EV-to-Forward-Revenue | 1.56 | |||||
EV-to-FCF | -25.05 | |||||
| Price-to-Net-Current-Asset-Value | 16.6 | |||||
Earnings Yield (Greenblatt) % | -3.37 | |||||
FCF Yield % | -3.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Minimed Group Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,387.925 | ||
| EPS (TTM) (€) | -0.924 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 52.93 | ||
| 14-Day ATR (€) | 0.670918 | ||
| 20-Day SMA (€) | 16.725 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 15.15 - 18 | ||
| Shares Outstanding (Mil) | 281.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Minimed Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Minimed Group Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Minimed Group Inc Frequently Asked Questions
What is Minimed Group Inc(STU:B8S)'s stock price today?
The current price of STU:B8S is €16.60. The 52 week high of STU:B8S is €18.00 and 52 week low is €15.15.
When is next earnings date of Minimed Group Inc(STU:B8S)?
The next earnings date of Minimed Group Inc(STU:B8S) is .
Does Minimed Group Inc(STU:B8S) pay dividends? If so, how much?
Minimed Group Inc(STU:B8S) does not pay dividend.
Press Release
Articles on Minimed Group Inc
No articles.